Literature DB >> 15056374

CD28 is not directly involved in the response of human CD3- CD56+ natural killer cells to lipopolysaccharide: a role for T cells.

M R Goodier1, M Londei.   

Abstract

We have previously shown that human CD3- CD56+ and CD3+ CD56+ cells from some individuals mount vigorous proliferative responses to lipopolysaccharide. Such responses have been blocked by the presence of cytotoxic T-lymphocyte antigen-4 immunoglobulin fusion protein in the cultures, implicating a role for B7-mediated costimulation. Here we confirm this inhibition of natural killer (NK) expansion using antibodies against B7-1 and B7-2. We were unable to specifically detect CD28 on the surface of resting or stimulated human peripheral blood NK cells, however, in either lipopolysaccharide-responsive or non-responsive individuals, using a panel of four different anti-CD28 monoclonal antibodies. T-cell depletion from peripheral blood mononuclear cell cultures resulted in a reduction in the induction of CD25 on activated CD3- CD56hi cells and in the expansion and proliferation of CD3- CD56+ NK cells. Furthermore, reconstitution experiments using peripheral blood dendritic cells and purified NK cells demonstrated that NK expansion could only be achieved in the presence of purified T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056374      PMCID: PMC1782433          DOI: 10.1111/j.0019-2805.2004.01834.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  NK cell triggering by the human costimulatory molecules CD80 and CD86.

Authors:  J L Wilson; J Charo; A Martín-Fontecha; P Dellabona; G Casorati; B J Chambers; R Kiessling; M T Bejarano; H G Ljunggren
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.

Authors:  B R Lauwerys; J C Renauld; F A Houssiau
Journal:  Cytokine       Date:  1999-11       Impact factor: 3.861

Review 3.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

Review 4.  Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.

Authors:  Julia Parrish-Novak; Donald C Foster; Richard D Holly; Christopher H Clegg
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

5.  Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Authors:  Khuong B Nguyen; Thais P Salazar-Mather; Marc Y Dalod; Jeffrey B Van Deusen; Xiao-qing Wei; Foo Y Liew; Michael A Caligiuri; Joan E Durbin; Christine A Biron
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.

Authors:  J Parrish-Novak; S R Dillon; A Nelson; A Hammond; C Sprecher; J A Gross; J Johnston; K Madden; W Xu; J West; S Schrader; S Burkhead; M Heipel; C Brandt; J L Kuijper; J Kramer; D Conklin; S R Presnell; J Berry; F Shiota; S Bort; K Hambly; S Mudri; C Clegg; M Moore; F J Grant; C Lofton-Day; T Gilbert; F Rayond; A Ching; L Yao; D Smith; P Webster; T Whitmore; M Maurer; K Kaushansky; R D Holly; D Foster
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

7.  Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.

Authors:  M R Goodier; M Londei
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

8.  Human NK cell-mediated cytotoxicity triggered by CD86 and Gal alpha 1,3-Gal is inhibited in genetically modified porcine cells.

Authors:  Cristina Costa; Domingo F Barber; William L Fodor
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

9.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

10.  Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.

Authors:  Guido Ferlazzo; Ming L Tsang; Lorenzo Moretta; Giovanni Melioli; Ralph M Steinman; Christian Münz
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  7 in total

1.  Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.

Authors:  Chihaya Imai; Shotaro Iwamoto; Dario Campana
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

2.  LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction.

Authors:  Olga Atochina; Donald Harn
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 3.  Clonal expansion of innate and adaptive lymphocytes.

Authors:  Nicholas M Adams; Simon Grassmann; Joseph C Sun
Journal:  Nat Rev Immunol       Date:  2020-05-18       Impact factor: 53.106

Review 4.  Utilizing chimeric antigen receptors to direct natural killer cell activity.

Authors:  David L Hermanson; Dan S Kaufman
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

5.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

Review 6.  CARs: Beyond T Cells and T Cell-Derived Signaling Domains.

Authors:  Nico M Sievers; Jan Dörrie; Niels Schaft
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 7.  Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.

Authors:  Damilola Oyewole-Said; Vanaja Konduri; Jonathan Vazquez-Perez; Scott A Weldon; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.